FDA
-
-
-
-
-
-
-
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
-
-
-
-
-
-
-
Pharma and Biotech Business Development Leaders to Discuss Psychedelics Partnering at Wonderland
-
-
-
-
-
-
-
Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants
-
-
-
-
-
-
-
Statement of Indivior on Grand Jury Indictment
-
-
-
-
-
-
-
Aquestive Therapeutics Inc. (AQST) Granted Temporary Restraining Order Against Alvogen
-
-
-
-
-
-
-
Court of Appeals for the Federal Circuit Declines to Immediately Issue Mandate After Preliminary Injunction Ruling
-
-
-
-
-
-
-
Indivior Unable to Participate in Morgan Stanley Healthcare Conference Due to Adverse Weather
-
323,583 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

